| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |